Trastuzumab Deruxtecan for Breast Cancer
- PMID: 35704495
- DOI: 10.1056/NEJMc2205309
Trastuzumab Deruxtecan for Breast Cancer
Comment in
-
Trastuzumab Deruxtecan for Breast Cancer. Reply.N Engl J Med. 2022 Jun 16;386(24):2347. doi: 10.1056/NEJMc2205309. N Engl J Med. 2022. PMID: 35704496 No abstract available.
Comment on
-
Trastuzumab Deruxtecan versus Trastuzumab Emtansine for Breast Cancer.N Engl J Med. 2022 Mar 24;386(12):1143-1154. doi: 10.1056/NEJMoa2115022. N Engl J Med. 2022. PMID: 35320644 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical